ArticleBMC urology2022

Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19.

Alfred Chung Pui So et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.